Physician profile
Hannah Jo
NPI 1164690616
$824.06
in general payments reported to CMS, 2019-2025
12 companies · $63.19 in 2025
The $63.19 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $284 · 2022: $319 · 2023: $39.37 · 2024: $119 · 2025: $63.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $176.30 | 2021-2022 | |
| Abbott Laboratories | $121.55 | 2022-2024 | Freestyle Libre 3 |
| Urovant Sciences INC | $121.52 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $92.05 | 2024-2025 | Adstiladrin |
| Janssen Biotech, INC. | $80.80 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $54.86 | 2021-2022 | |
| 180 Medical, INC. | $51.91 | 2022-2024 | |
| Abbvie INC. | $37.82 | 2021-2023 | |
| Tolmar, INC. | $30.46 | 2025 | Jatenzo |
| Blue Earth Diagnostics | $21.01 | 2022 | |
| Astellas Pharma US INC | $18.23 | 2021 | |
| Merck Sharp & Dohme LLC | $17.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Jo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.